Is dronedarone effective for the prevention of recurrent atrial fibrillation?
White
C Michael
CM
University of Connecticut, Hartford Hospital, Hartford, CT 06102-5037, USA. cmwhite@harthosp.org
D000638:Amiodarone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000175:diagnosis / Q000188:drug therapy* / Q000401:mortality; D016001:Confidence Intervals; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D000077764:Dronedarone; D004334:Drug Administration Schedule; D004562:Electrocardiography; D005260:Female; D006801:Humans; D008297:Male; D015337:Multicenter Studies as Topic; D011336:Probability; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic; D055502:Secondary Prevention; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index; D015996:Survival Rate; D016896:Treatment Outcome
D000077764:Dronedarone; D000638:Amiodarone